The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis
Background: Programmed cell death ligand 1 (PD-L1) expression has been shown to correlate with poor prognosis in diverse human cancers. However, limited data exist on the prognostic and clinicopathologic significance of PD-L1 expression in prostate cancers (PCa), and the curative effect of anti-PD-1...
Guardado en:
Autores principales: | Yan Li (Autor), Qingying Huang (Autor), Yaoyao Zhou (Autor), Meizhi He (Autor), Jianhong Chen (Autor), Yubo Gao (Autor), Xue Wang (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Frontiers Media S.A.,
2019-01-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Yan Li, et al.
Publicado: (2019) -
Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis
por: Lei Zhu, et al.
Publicado: (2019) -
Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas
por: Opal L. Reddy, et al.
Publicado: (2017) -
Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer
por: Maureen L. Drakes, et al.
Publicado: (2018) -
Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1), CD8+ Tumor-Infiltrating Lymphocytes and p53 in Non-Small Cell Lung Cancer: An Immunohistochemical Study
por: Hayam E. RASHED, et al.
Publicado: (2017)